TXG
10x Genomics, Inc. Class A Common StockstockNASDAQ
advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 62.90 | 2026-11-10 | -13.78% | 1.277 |
| 1M | 69.86 | 2026-10-16 | -22.37% | 3.832 |
| 3M | 57.99 | 2026-08-17 | -6.48% | 3.261 |
| 6M | 21.45 | 2026-05-18 | +152.82% | 2.971 |
| 1Y | 15.70 | 2025-11-17 | +245.41% | 2.478 |
| 2Y | 13.18 | 2024-11-18 | +311.46% | — |
| 5Y | 160.27 | 2021-11-17 | -66.16% | 2.128 |
10x Genomics, Inc. Class A Common Stock (NASDAQ:TXG) stock price today is $54.23, and today's volume is 331,332. TXG is down 1.382% today. The 30 day average volume is 3.82M. TXG market cap is $7.13B with 131.53M shares outstanding.